about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesAldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsBone microenvironment signals in osteosarcoma development.Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation.FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
P50
Q26745742-ED5DAA70-107E-49F6-9DA0-7F87E539D7BAQ27342050-37B44104-A9BF-46BD-B4E4-D683F9E7BFA2Q28597747-EC9FF705-D33B-433C-B079-E2BA0BCC739CQ33649056-82633CDF-019D-46CA-A95F-A5A0A9B6AD8EQ38454980-2D210588-28C8-4C0B-A78D-B7F137A0BBB9Q39032517-A406CCBD-0BC7-4ADF-97AD-6F03C8A70E71Q39128691-022DE116-E642-4973-B799-B2EEF3C31AF8Q47391013-DB52E045-6382-497A-8F81-77691CA803CCQ92421507-DDD43982-5F5B-4595-8B87-F334EA60470A
P50
description
Investigador ORCID:0000-0002-7676-3958
@ca
Investigador ORCID:0000-0002-7676-3958
@es
Researcher ORCID: 0000-0002-7676-3958
@en
name
Juan Tornin Cavielles
@ca
Juan Tornin Cavielles
@en
Juan Tornin Cavielles
@es
Juan Tornin Cavielles
@nl
type
label
Juan Tornin Cavielles
@ca
Juan Tornin Cavielles
@en
Juan Tornin Cavielles
@es
Juan Tornin Cavielles
@nl
prefLabel
Juan Tornin Cavielles
@ca
Juan Tornin Cavielles
@en
Juan Tornin Cavielles
@es
Juan Tornin Cavielles
@nl
P106
P21
P31
P496
0000-0002-7676-3958